Supression of telomerase activity in HL60 cells after treatment with differentiating agents - PubMed (original) (raw)
Affiliations
- PMID: 8709642
Supression of telomerase activity in HL60 cells after treatment with differentiating agents
D Xu et al. Leukemia. 1996 Aug.
Abstract
The human promyelocytic leukemic HL60 cells are immortal and as such express high levels of telomerase activity. All-trans retinoic acid (ATRA) and 1 alpha, 25 dihydroxyvitamin D3 (VD3) induce differentiation of HL60 cells into CD11b+ mature granulocytes and monocytes, respectively. We studied telomerase activity after differentiation of HL60 cells. A marked inhibition of the enzyme activity was observed in the differentiated CD11b+ cells after 72-120 h treatment with either differentiating agent. In contrast, the VD3-treated CD11b- HL60 cells, which failed to undergo differentiation and human erythroleukemic cell line K562, exposed to ATRA retained high levels of telomerase activity. This finding suggests, that telomerase activity is repressed as a differentiation-associated event in HL60 cells. Our results provide the first evidence that immortal leukemic cells, like normal human cells, have a telomerase repressing mechanism which can be activated by differentiation and thus lead to the suppression of telomerase activity. This in vitro model may be useful for studies of the mechanisms controlling telomerase activity and in the search for physiological telomerase modulators.
Similar articles
- Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein.
Reichman TW, Albanell J, Wang X, Moore MA, Studzinski GP. Reichman TW, et al. J Cell Biochem. 1997 Oct 1;67(1):13-23. J Cell Biochem. 1997. PMID: 9328835 - Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines.
Hussain AM, Lee HC, Chang CF. Hussain AM, et al. Eur J Cell Biol. 2000 Oct;79(10):697-706. doi: 10.1078/0171-9335-00099. Eur J Cell Biol. 2000. PMID: 11089918 - Multistep regulation of telomerase during differentiation of HL60 cells.
Yamada O, Ozaki K, Nakatake M, Akiyama M, Kawauchi K, Matsuoka R. Yamada O, et al. J Leukoc Biol. 2008 May;83(5):1240-8. doi: 10.1189/jlb.1207848. Epub 2008 Feb 14. J Leukoc Biol. 2008. PMID: 18276798
Cited by
- Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.
Melicher D, Buzas EI, Falus A. Melicher D, et al. Cell Mol Life Sci. 2015 Nov;72(21):4095-109. doi: 10.1007/s00018-015-1991-2. Epub 2015 Jul 20. Cell Mol Life Sci. 2015. PMID: 26190020 Free PMC article. Review. - Promoter G-quadruplex sequences are targets for base oxidation and strand cleavage during hypoxia-induced transcription.
Clark DW, Phang T, Edwards MG, Geraci MW, Gillespie MN. Clark DW, et al. Free Radic Biol Med. 2012 Jul 1;53(1):51-9. doi: 10.1016/j.freeradbiomed.2012.04.024. Epub 2012 May 1. Free Radic Biol Med. 2012. PMID: 22583700 Free PMC article. - Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
Zhu Q, Liu C, Ge Z, Fang X, Zhang X, Strååt K, Björkholm M, Xu D. Zhu Q, et al. PLoS One. 2008 Jan 16;3(1):e1446. doi: 10.1371/journal.pone.0001446. PLoS One. 2008. PMID: 18197256 Free PMC article. - Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.
Liu DY, Peng ZH, Qiu GQ, Zhou CZ. Liu DY, et al. World J Gastroenterol. 2003 Aug;9(8):1859-62. doi: 10.3748/wjg.v9.i8.1859. World J Gastroenterol. 2003. PMID: 12918139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials